U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne

NCT01446237 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

OTHER: acne system - benzoyl peroxide 2.5%, Salicyclic Acid 0.5%

Sponsor

Stiefel, a GSK Company

Collaborators

[object Object]